Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Freya Pharma Solutions, a company focusing on therapies for women diagnosed with Female Sexual Disorders (FSD), announced the appointment of Christa van Kan, MSc as Director Clinical Operations.
read more
Glenmark Pharmaceuticals and Cediprof, Inc. (a part of the Neolpharma Pharmaceutical Group family of companies) have entered into an exclusive supply and distribution agreement for Cediprof's FDA-approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity ...
read more
Endo International announced that one of its operating companies, Par Pharmaceutical, has begun shipping the first generic version of Allergan's Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) 140 mg, 125 mg and 125 mg capsules in the U.S., following final approval from the U.S. Food and Drug Administration of its ...
read more
SPI Pharma, Inc. (SPI), a global pharmaceutical formulations supplier, announces that it has received sole distribution rights for CELLETS® MCC pellets and TAP® tartaric acid pellets, from ingredientpharm . SPI also received the sole distribution rights to directly compressible Ibuprofen DC100.
read more
The U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application (sNDA) for Jardiance® (empagliflozin) investigating a potential new indication to lower blood sugar along with diet and exercise in children 10 years and older with type 2 diabetes, Boehringer Ingelheim and Eli Lilly announced.
read more
By end-user, the pharmaceutical industries segment held around three-fourths of the global formulation development outsourcing market share in 2021, and is projected to dominate by 2031. The same segment would also cite the fastest CAGR of 9.3% from 2022 to 2031.
read more
Currax Pharmaceuticals, a US biopharmaceutical company filed a complaint alleging that Found Health is falsely marketing medications to patients as the generic equivalent of CONTRAVE® when no generic equivalent exists.
read more
Upsher-Smith announced the launch of dicyclomine hydrochloride tablets, USP 20 mg. This product launch is a result of Upsher-Smith's partnership with CorePharma LLC, a product developer and manufacturer.
read more
The global pharmaceutical packaging market is expected to reach $265.70B by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a study by Grand View Research.
read more
The sustained release excipients market size is estimated at $139B in 2022 and is expected to witness a CAGR of 8.62% during the forecast period 2023-2033, according to a report by Research & Markets.
read more
The global live cell encapsulation market is projected to reach $286.5M by 2030, registering a CAGR of 3.97% during the forecast period, according to a report by Grand View Research.
read more
The Global Liver Health Supplements Market is estimated to be $1.05B in 2022 and is expected to reach $1.69B by 2027, growing at a CAGR of 10.02%, according to a report by Research & Markets.
read more
The Attention Deficit Hyperactivity Disorder (ADHD) drugs market size is forecast to grow by $9.61B between 2020 and 2025 at a CAGR of 9.06%, according to a report by Technavio.
read more
Accord Healthcare, a pharmaceutical company, has added Lurasidone HCL tablets to its line of generic drugs.
read more
The global antihypertensive drugs market size was worth around $20.5B in 2021 and is predicted to grow to around $39.5B by 2030, with a compound annual growth rate (CAGR) of roughly 2.95% between 2022 and 2030, according to a Facts and Factors study,
read more